Drug Profile
BS 51
Alternative Names: BS-51Latest Information Update: 28 Jul 2021
Price :
$50
*
At a glance
- Originator Hangzhou Bensheng Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 28 Jul 2021 No recent reports of development identified for research development in Colorectal-cancer in China
- 06 Jun 2017 Early research in Colorectal cancer in China before June 2017 (Hangzhou Bensheng Pharma pipeline, June 2017)